StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) stock

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$690.24−10.41 (-1.49%)

Close on Nov 17, 2026Market cap $54.38BP/E 48.5Yield –

IDEXX Laboratories operating margin

Operating margin is operating income as a percentage of revenue.

IDEXX Laboratories's operating margin for the twelve months ending Jun 30, 2026 was 32.0%. For fiscal 2025 it was 31.6%, against 29.0% the year before. The highest annual figure on record is 31.6% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202531.6%+2.7
FY2024Dec 31, 202429.0%−1.0
FY2023Dec 31, 202330.0%+3.3
FY2022Dec 31, 202226.7%−2.3
FY2021Dec 31, 202129.0%+3.3
FY2020Dec 31, 202025.7%+2.7
FY2019Dec 31, 201923.0%+0.8
FY2018Dec 31, 201822.2%+1.2
FY2017Dec 31, 201721.0%+1.2
FY2016Dec 31, 201619.7%+1.0
FY2015Dec 31, 201518.7%+1.2
FY2014Dec 31, 201417.5%−1.9
FY2013Dec 31, 201319.4%−0.9
FY2012Dec 31, 201220.3%+0.9
FY2011Dec 31, 201119.4%+0.9
FY2010Dec 31, 201018.5%+1.4
FY2009Dec 31, 200917.1%+0.2
FY2008Dec 31, 200816.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202635.0%+1.4
Q1 FY2026Mar 31, 202631.8%+0.1
Q4 FY2025Dec 31, 202528.9%+1.5
Q3 FY2025Sep 30, 202532.1%+1.0
Q2 FY2025Jun 30, 202533.6%+7.3
Q1 FY2025Mar 31, 202531.7%+0.7
Q4 FY2024Dec 31, 202427.4%+0.2
Q3 FY2024Sep 30, 202431.2%+1.1
Q2 FY2024Jun 30, 202426.3%−5.1
Q1 FY2024Mar 31, 202431.0%−0.1
Q4 FY2023Dec 31, 202327.2%−0.1
Q3 FY2023Sep 30, 202330.1%+1.0
Q2 FY2023Jun 30, 202331.4%+10.6
Q1 FY2023Mar 31, 202331.1%+1.5
Q4 FY2022Dec 31, 202227.3%+2.5
Q3 FY2022Sep 30, 202229.1%+1.2
Q2 FY2022Jun 30, 202220.8%−10.6
Q1 FY2022Mar 31, 202229.7%−2.2
Q4 FY2021Dec 31, 202124.9%−0.8
Q3 FY2021Sep 30, 202127.9%+4.1
Q2 FY2021Jun 30, 202131.4%+1.1
Q1 FY2021Mar 31, 202131.8%+8.8
Q4 FY2020Dec 31, 202025.7%+6.6
Q3 FY2020Sep 30, 202023.8%+0.7
Q2 FY2020Jun 30, 202030.3%+3.8
Q1 FY2020Mar 31, 202023.0%−0.1
Q4 FY2019Dec 31, 201919.1%−1.9
Q3 FY2019Sep 30, 201923.1%+1.6
Q2 FY2019Jun 30, 201926.5%+1.4
Q1 FY2019Mar 31, 201923.1%+2.1
Q4 FY2018Dec 31, 201821.0%+1.7
Q3 FY2018Sep 30, 201821.5%+1.1
Q2 FY2018Jun 30, 201825.1%+1.0
Q1 FY2018Mar 31, 201821.0%+1.1
Q4 FY2017Dec 31, 201719.3%+0.4
Q3 FY2017Sep 30, 201720.4%+0.7
Q2 FY2017Jun 30, 201724.1%–
Q1 FY2017Mar 31, 201720.0%–
Q4 FY2016Dec 31, 201618.9%–
Q3 FY2016Sep 30, 201619.7%–

More IDEXX Laboratories figures

See a number that looks wrong?